Internal medicine, Pathology, Cirrhosis, Gastroenterology and Immunology are his primary areas of study. Robert D. Goldin combines topics linked to Endocrinology with his work on Internal medicine. The various areas that he examines in his Pathology study include Absorption, Terahertz radiation, Terahertz pulsed imaging and Liver injury.
Robert D. Goldin combines subjects such as Liver disease, Steatosis and Hepatitis C virus with his study of Cirrhosis. His Gastroenterology research is multidisciplinary, incorporating elements of Fibrosis, Hepatitis B, Lamivudine and Liver biopsy. His Immunology study combines topics from a wide range of disciplines, such as Cancer research and Pharmacology.
His primary areas of investigation include Internal medicine, Pathology, Gastroenterology, Immunology and Liver disease. His work investigates the relationship between Internal medicine and topics such as Oncology that intersect with problems in Colorectal cancer. In his research, Steatohepatitis is intimately related to Steatosis, which falls under the overarching field of Pathology.
His studies in Gastroenterology integrate themes in fields like Hepatitis C, Surgery and Hepatitis C virus. Immunology is closely attributed to Virology in his study. His Liver disease research integrates issues from Hepatitis B and Hepatitis.
The scientist’s investigation covers issues in Internal medicine, Cancer research, Gastroenterology, Immune system and Colorectal cancer. His Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology. His work in Gastroenterology covers topics such as Steatohepatitis which are related to areas like Liver disease.
Within one scientific family, he focuses on topics pertaining to Fibrosis under Liver disease, and may sometimes address concerns connected to Insulin resistance. The Immune system study combines topics in areas such as Hepatocellular carcinoma and Monocyte. His work in Programmed cell death ligand 1 tackles topics such as Pathology which are related to areas like Cell.
His scientific interests lie mostly in Internal medicine, Fibrosis, Prospective cohort study, Cell biology and Biopsy. His Gastroenterology research extends to the thematically linked field of Internal medicine. His Fibrosis study incorporates themes from Nonalcoholic fatty liver disease, Endocrinology, Steatohepatitis and Insulin resistance.
The concepts of his Prospective cohort study study are interwoven with issues in Mean platelet volume, Retrospective cohort study, Univariate analysis and Cohort. His biological study spans a wide range of topics, including Inflammation, Intestinal mucosa and Goblet cell. The study incorporates disciplines such as Adverse effect and Clinical trial in addition to Biopsy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Histological outcome during long-term lamivudine therapy
Jules L. Dienstag;Robert D. Goldin;E.Jenny Heathcote;H.W.L. Hann.
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document
S A Khan;B R Davidson;R Goldin;S P Pereira.
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research
Quentin M. Anstee;Robert D. Goldin.
International Journal of Experimental Pathology (2006)
Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis
Saul N. Faust;Michael Levin;Odile B. Harrison;Robert D. Goldin.
The New England Journal of Medicine (2001)
Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis
G. R. Foster;R. D. Goldin;H. C. Thomas.
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group.
Tassopoulos Nc;Volpes R;Pastore G;Heathcote J.
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A Khan;Brian R Davidson;Robert D Goldin;Nigel Heaton.
Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique.
Elizabeth A. Stewart;Wladyslaw M.W. Gedroyc;Clare M.C. Tempany;Bradley J. Quade.
American Journal of Obstetrics and Gynecology (2003)
Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study
E L Thomas;G Hamilton;N Patel;R O’Dwyer.
Influence of MHC class II genotype on outcome of infection with hepatitis C virus
Mark Thursz;Rhiannon Yallop;Robert Goldin;Christian Trepo.
The Lancet (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: